ArticleFrontiers in pharmacology2021

Pim1 Kinase Inhibitors Exert Anti-Cancer Activity Against HER2-Positive Breast Cancer Cells Through Downregulation of HER2.

Bo-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.